Choline deficiency associated with diethanolamine carcinogenicity

被引:0
|
作者
Newberne, PM [1 ]
机构
[1] Boston Univ, Sch Med, Dept Pathol, Boston, MA 02118 USA
关键词
D O I
暂无
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
引用
收藏
页码:1 / 3
页数:3
相关论文
共 50 条
  • [1] Diethanolamine induces hepatic choline deficiency in mice
    Lehman-McKeeman, LD
    Gamsky, EA
    Hicks, SM
    Vassallo, JD
    Mar, MH
    Zeisel, SH
    TOXICOLOGICAL SCIENCES, 2002, 67 (01) : 38 - 45
  • [2] Review of the carcinogenic activity of diethanolamine and evidence of choline deficiency as a plausible mode of action
    Leung, HW
    Kamendulis, LM
    Stott, WT
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2005, 43 (03) : 260 - 271
  • [3] VASCULAR DISEASE ASSOCIATED WITH CHOLINE DEFICIENCY IN THE RAT
    WILGRAM, GF
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 1958, 6 (03): : 274 - 279
  • [4] CHOLINE DEFICIENCY ASSOCIATED WITH TOTAL PARENTERAL-NUTRITION
    BURT, ME
    HANIN, I
    BRENNAN, MF
    LANCET, 1980, 2 (8195): : 638 - 639
  • [5] CHOLINE DEFICIENCY
    ZEISEL, SH
    JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 1990, 1 (07): : 332 - 349
  • [6] Choline deficiency and TPN associated liver dysfunction: A case report
    Hager, L
    NUTRITION, 1998, 14 (01) : 60 - 62
  • [7] Choline deficiency is associated with increased risk for venous catheter thrombosis
    Buchman, Alan L.
    Ament, Marvin E.
    Jenden, Donald J.
    Ahn, Chul
    JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2006, 30 (04) : 317 - 320
  • [8] Choline deficiency is associated with increased risk for venous catheter thrombosis
    Buchman, Alan L.
    Ament, Marvin E.
    Jendon, Donald J.
    Ahn, Chul
    GASTROENTEROLOGY, 2006, 130 (04) : A612 - A612
  • [9] Diethanolamine alters proliferation and choline metabolism in mouse neural precursor cells
    Niculescu, Mihai D.
    Wu, Renan
    Guo, Zhong
    da Costa, Kerry Ann
    Zeisel, Steven H.
    TOXICOLOGICAL SCIENCES, 2007, 96 (02) : 321 - 326
  • [10] AUREOMYCIN IN CHOLINE DEFICIENCY
    BAXTER, JH
    HUNSTIGER, H
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1951, 103 (04): : 337 - 338